Critical Reviews in Oncology / Hematology
Volume 77, Issue 2 , Pages 100-108 , February 2011

Global graying, colorectal cancer and liver metastasis: New implications for surgical management

  • Daniel A. Anaya

      Affiliations

    • Department of Surgery – Surgical Oncology, Michael E. DeBakey VA Medical Center, Houston, TX, United States
    • Houston Center for Quality of Care & Utilization Studies, United States
    • Baylor College of Medicine, Houston, TX, United States
    • Corresponding Author InformationCorresponding author at: Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd, OCL (112), Houston, TX 77030, United States. Tel.: +1 713 794 8026; fax: +1 713 794 7352.
    • ,
  • Natasha S. Becker

      Affiliations

    • Department of Surgery – Surgical Oncology, Michael E. DeBakey VA Medical Center, Houston, TX, United States
    • Baylor College of Medicine, Houston, TX, United States
    • ,
  • Neena S. Abraham

      Affiliations

    • Houston Center for Quality of Care & Utilization Studies, United States
    • Gastroenterology Outcomes in Geriatrics (GO-GERI) Unit, United States
    • Department of Medicine, Gastroenterology at the Michael E. DeBakey VA Medical Center, Houston, TX, United States
    • Baylor College of Medicine, Houston, TX, United States

,Accepted 5 February 2010.

References 

  1. Nadakavukaren A. Population dynamics. In:  Nadakavukaren A editors. Our global environment. 6th ed.. Long Grove (IL): Waveland Press, Inc.; 2006;p. 39–71
  2. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766–2792
  3. Aging—trends in aging by world region, 2006. Population Reference Bureau. 2009;Available at: URL: http://www.prb.org/Home/Publications/GraphicsBank/Aging.aspx [accessed 15.06.09]
  4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249
  5. Poston GJ, Adam R, Alberts S, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23:7125–7134
  6. Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101-4–106
  7. World population ageing 2007. United Nations Department of Economic and Social Affairs, Population Division; 2009;Available at: URL: http://www.un.org/esa/population/publications/WPA2007 [accessed 18.09.09]
  8. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–2765
  9. Engstrom P. Update: NCCN colon cancer clinical practice guidelines. J Natl Compr Canc Netw. 2005;(Suppl. 1):S25–S28
  10. Engstrom PF, Benson AB, Chen YJ, et al. Colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2009;7:778–831
  11. Engstrom PF, Benson AB, Chen YJ, et al. Rectal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005;3:492–508
  12. Colorectal Cancer Collaborative Group . Surgery for colorectal cancer in elderly patients: a systematic review. Lancet. 2000;356:968–974
  13. Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007;246:215–221
  14. Damhuis RA, Meurs CJ, Meijer WS. Postoperative mortality after cancer surgery in octogenarians and nonagenarians: results from a series of 5,390 patients. World J Surg Oncol. 2005;3:71
  15. Kornmann M, Formentini A, Ette C, et al. Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol. 2008;34:1316–1321
  16. Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis. 2009;11:157–161
  17. Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg. 2008;248:968–978
  18. Schiffmann L, Ozcan S, Schwarz F, Lange J, Prall F, Klar E. Colorectal cancer in the elderly: surgical treatment and long-term survival. Int J Colorectal Dis. 2008;23:601–610
  19. Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26:380–385
  20. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005;16:756–761
  21. Quaglia A, Tavilla A, Shack L, et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer. 2009;45:1006–1016
  22. van Leeuwen BL, Pahlman L, Gunnarsson U, Sjovall A, Martling A. The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol. 2008;67:229–236
  23. Aalami OO, Fang TD, Song HM, Nacamuli RP. Physiological features of aging persons. Arch Surg. 2003;138:1068–1076
  24. Arai T, Takubo K. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int. 2007;57:303–314
  25. Loran DB, Hyde BR, Zwischenberger JB. Perioperative management of special populations: the geriatric patient. Surg Clin North Am. 2005;85:1259–1266xi
  26. Abraham NS, Gossey JT, Davila JA, Al-Oudat S, Kramer JK. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol. 2006;101:1320–1328
  27. Aapro MS, Kohne CH, Cohen HJ, Extermann M. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist. 2005;10:198–204
  28. Papamichael D. Challenges in treating older cancer patients: colon cancer. Ann Oncol. 2008;19(Suppl. 7):vii104–vii108
  29. Fentiman IS, Tirelli U, Monfardini S, et al. Cancer in the elderly: why so badly treated?. Lancet. 1990;335:1020–1022
  30. Ramesh HS, Jain S, Audisio RA. Implications of aging in surgical oncology. Cancer J. 2005;11:488–494
  31. McGory ML, Kao KK, Shekelle PG, et al. Developing quality indicators for elderly surgical patients. Ann Surg. 2009;250:338–347
  32. McGory ML, Shekelle PG, Rubenstein LZ, Fink A, Ko CY. Developing quality indicators for elderly patients undergoing abdominal operations. J Am Coll Surg. 2005;201:870–883
  33. Audisio RA, Veronesi P, Ferrario L, Cipolla C, Andreoni B, Aapro M. Elective surgery for gastrointestinal tumours in the elderly. Ann Oncol. 1997;8:317–326
  34. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25:1824–1831
  35. Heriot AG, Tekkis PP, Smith JJ, et al. Prediction of postoperative mortality in elderly patients with colorectal cancer. Dis Colon Rectum. 2006;49:816–824
  36. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494–502
  37. Terret C, Zulian GB, Naiem A, Albrand G. Multidisciplinary approach to the geriatric oncology patient. J Clin Oncol. 2007;25:1876–1881
  38. Terret C. How and why to perform a geriatric assessment in clinical practice. Ann Oncol. 2008;19(Suppl. 7):vii300–vii303
  39. Pope D, Ramesh H, Gennari R, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15:189–197
  40. Audisio RA, Pope D, Ramesh HS, et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008;65:156–163
  41. Papamichael D, Audisio R, Horiot JC, et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol. 2009;20:5–16
  42. NIH Consensus Conference . Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444–1450
  43. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703–2711
  44. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345:1091–1097
  45. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002;136:349–357
  46. Lembersky BC, Wieand HS, Petrelli NJ, et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol. 2006;24:2059–2064
  47. Popescu RA, Norman A, Ross PJ, Parikh B, Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol. 1999;17:2412–2418
  48. Scheithauer W, McKendrick J, Begbie S, et al. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol. 2003;14:1735–1743
  49. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg. 2006;93:465–474
  50. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–259
  51. Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109:718–726
  52. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677–3683
  53. Dimick JB, Wainess RM, Cowan JA, Upchurch GR, Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg. 2004;199:31–38
  54. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982–999
  55. van Leeuwen BL, de Liguori Carino N, Poston GJ. Surgical treatment of colorectal liver metastases in elderly patients. In:  Vauthey J-N,  Hoff PMG,  RAudisio RA,  Poston GJ editor. Liver metastases. 1st ed.. London: Springer; 2009;p. 111–116
  56. Brand MI, Saclarides TJ, Dobson HD, Millikan KW. Liver resection for colorectal cancer: liver metastases in the aged. Am Surg. 2000;66:412–415
  57. Brunken C, Rogiers X, Malago M, Broelsch CE. Is resection of colorectal liver metastases in patients over 70 years of age indicated?. Langenbecks Arch Chir Suppl Kongressbd. 1996;113:505–508
  58. Brunken C, Rogiers X, Malago M, et al. Is resection of colorectal liver metastases still justified in very elderly patients?. Chirurg. 1998;69:1334–1339
  59. de Liguori CN, van Leeuwen BL, Ghaneh P, Wu A, Audisio RA, Poston GJ. Liver resection for colorectal liver metastases in older patients. Crit Rev Oncol Hematol. 2008;67:273–278
  60. Figueras J, Ramos E, Lopez-Ben S, et al. Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile?. Clin Transl Oncol. 2007;9:392–400
  61. Mazzoni G, Tocchi A, Miccini M, et al. Surgical treatment of liver metastases from colorectal cancer in elderly patients. Int J Colorectal Dis. 2007;22:77–83
  62. Nagano Y, Nojiri K, Matsuo K, et al. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg. 2005;201:511–516
  63. Turrini O, Guiramand J, Moutardier V, et al. [Major hepatectomy for metastasis of colorectal cancer improves survival in the elderly]. Ann Chir. 2005;130:562–565
  64. Zacharias T, Jaeck D, Oussoultzoglou E, Bachellier P, Weber JC. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg. 2004;240:858–865
  65. Zieren HU, Muller JM, Zieren J, Pichlmaier H. The impact of patient's age on surgical therapy of colorectal liver metastases. Int Surg. 1993;78:288–291
  66. Zieren HU, Muller JM, Zieren J. Resection of colorectal liver metastases in old patients. Hepatogastroenterology. 1994;41:34–37
  67. Mann CD, Neal CP, Pattenden CJ, et al. Major resection of hepatic colorectal liver metastases in elderly patients–an aggressive approach is justified. Eur J Surg Oncol. 2008;34:428–432
  68. Nojiri K, Nagano Y, Tanaka K, et al. Validity of hepatic resection of colorectal liver metastases in the elderly (75 years and older). Anticancer Res. 2009;29:583–588
  69. Kristjansson SR, Farinella E, Gaskell S, Audisio RA. Surgical risk and post-operative complications in older unfit cancer patients. Cancer Treat Rev. 2009;35:499–502
  70. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318
  71. Mayo SC, Pawlik TM. Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol. 2009;3:131–144
  72. Ribero D, Chun Y, Vauthey J. Surgery for colorectal metastases. In:  Vauthey JN,  Hoff PMG,  Audisio RA,  Poston GJ editor. Liver metastases. 1st ed.. London: Springer; 2009;p. 25–38
  73. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–766
  74. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1271–1280
  75. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–862
  76. Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer. 2009;115:752–759
  77. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–825
  78. Blazer DG, Anaya DA, Abdalla EK. Destructive therapies for colorectal cancer metastases. In:  Vauthey JN,  Hoff PMG,  Audisio RA,  Poston GJ editor. Liver metastases. 1st ed.. London: Springer; 2009;p. 39–50
  79. Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol. 2008;26:4906–4911
  80. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol. 2006;24:4976–4982
  81. Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol. 2009;16:2385–2390
  82. Blazer DG, Kishi Y, Maru DM, et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008;26:5344–5351
  83. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol. 2003;14(Suppl 2):ii13–16
  84. Adam R, Huguet E, Azoulay D, et al. Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am. 2003;12:211–220xii
  85. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644–657
  86. Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?. J Clin Oncol. 2009;27:1829–1835
  87. Giacchetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999;10:663–669
  88. Karoui M, Penna C, min-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006;243:1–7
  89. Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol. 2008;34:609–614
  90. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274–286
  91. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49–57
  92. Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar Cholangiocarcinoma. Semin Interv Radiol. 2009;25:110–122
  93. Timchenko NA. Aging and liver regeneration. Trends Endo Metab. 2009;20:171–176
  94. Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;[Epub ahead of print]
  95. Heffernan N, Cella D, Webster K, et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy—hepatobiliary questionnaire. J Clin Oncol. 2002;20:2229–2239
  96. Kavadas V, Blazeby JM, Conroy T, et al. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer. 2003;39:1259–1263
  97. Efficace F, Innominato PF, Bjarnason G, et al. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2008;26:2020–2026

PII: S1040-8428(10)00033-8

doi: 10.1016/j.critrevonc.2010.02.003

Critical Reviews in Oncology / Hematology
Volume 77, Issue 2 , Pages 100-108 , February 2011

Article Tools